Detalhe da pesquisa
1.
Publisher Correction: Actively personalized vaccination trial for newly diagnosed glioblastoma.
Nature
; 566(7745): E13, 2019 02.
Artigo
Inglês
| MEDLINE | ID: mdl-30733620
2.
Actively personalized vaccination trial for newly diagnosed glioblastoma.
Nature
; 565(7738): 240-245, 2019 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30568303
3.
Pitfalls in HLA Ligandomics-How to Catch a Li(e)gand.
Mol Cell Proteomics
; 20: 100110, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34129939
4.
Translating Immunopeptidomics to Immunotherapy-Decision-Making for Patient and Personalized Target Selection.
Proteomics
; 18(12): e1700284, 2018 06.
Artigo
Inglês
| MEDLINE | ID: mdl-29505699
5.
Natural HLA class I ligands from glioblastoma: extending the options for immunotherapy.
J Neurooncol
; 111(3): 285-94, 2013 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-23263746
6.
Exploiting the glioblastoma peptidome to discover novel tumour-associated antigens for immunotherapy.
Brain
; 135(Pt 4): 1042-54, 2012 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-22418738
7.
Feasibility and Safety of Personalized, Multi-Target, Adoptive Cell Therapy (IMA101): First-in-Human Clinical Trial in Patients with Advanced Metastatic Cancer.
Cancer Immunol Res
; 11(7): 925-945, 2023 07 05.
Artigo
Inglês
| MEDLINE | ID: mdl-37172100
8.
Quantitative immunopeptidomics reveals a tumor stroma-specific target for T cell therapy.
Sci Transl Med
; 14(660): eabo6135, 2022 08 31.
Artigo
Inglês
| MEDLINE | ID: mdl-36044599
9.
RNA editing derived epitopes function as cancer antigens to elicit immune responses.
Nat Commun
; 9(1): 3919, 2018 09 25.
Artigo
Inglês
| MEDLINE | ID: mdl-30254248
10.
Unexpected abundance of HLA class II presented peptides in primary renal cell carcinomas.
Clin Cancer Res
; 12(14 Pt 1): 4163-70, 2006 Jul 15.
Artigo
Inglês
| MEDLINE | ID: mdl-16857787
11.
Autophagy in innate and adaptive immunity against intracellular pathogens.
J Mol Med (Berl)
; 84(3): 194-202, 2006 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-16501849
12.
Effects of imatinib on monocyte-derived dendritic cells are mediated by inhibition of nuclear factor-kappaB and Akt signaling pathways.
Clin Cancer Res
; 11(5): 1928-40, 2005 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-15756019
13.
Integrated functional genomics approach for the design of patient-individual antitumor vaccines.
Cancer Res
; 62(20): 5818-27, 2002 Oct 15.
Artigo
Inglês
| MEDLINE | ID: mdl-12384544
14.
Induction of adipophilin-specific cytotoxic T lymphocytes using a novel HLA-A2-binding peptide that mediates tumor cell lysis.
Cancer Res
; 64(3): 1164-70, 2004 Feb 01.
Artigo
Inglês
| MEDLINE | ID: mdl-14871853
15.
A Cancer Research UK First Time in Human Phase I Trial of IMA950 (Novel Multipeptide Therapeutic Vaccine) in Patients with Newly Diagnosed Glioblastoma.
Clin Cancer Res
; 22(19): 4776-4785, 2016 Oct 01.
Artigo
Inglês
| MEDLINE | ID: mdl-27225692
16.
MAGED4-expression in renal cell carcinoma and identification of an HLA-A*25-restricted MHC class I ligand from solid tumor tissue.
Cancer Biol Ther
; 4(9): 943-8, 2005 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-16082191
17.
Production and characterization of amplified tumor-derived cRNA libraries to be used as vaccines against metastatic melanomas.
Genet Vaccines Ther
; 3: 6, 2005 Aug 22.
Artigo
Inglês
| MEDLINE | ID: mdl-16115316
18.
Moderate degradation does not preclude microarray analysis of small amounts of RNA.
Biotechniques
; 35(6): 1192-6, 1198-201, 2003 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-14682053
19.
Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival.
Nat Med
; 18(8): 1254-61, 2012 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-22842478
20.
A cryptic vascular endothelial growth factor T-cell epitope: identification and characterization by mass spectrometry and T-cell assays.
Cancer Res
; 68(7): 2447-54, 2008 Apr 01.
Artigo
Inglês
| MEDLINE | ID: mdl-18381453